FIELD: medicine. SUBSTANCE: method involves acting upon myofascial trigger zone in complex stage-by-stage mode having in view structural neurometameric organization. The treatment is first applied to opposite side in the healthy vertebral locomotor segment projection and large extremity articulation area. Then, the side of blocked vertebral locomotor segment projection and pathologically transformed articulation. To do it, cutanofascial techniques and musculofascial relaxation are applied first in paravertebral area. Rhythmic mobilization is carried out by pressing tenor and hypotenor areas against the costovertebral and costotransverse articulations and/or against the costovertebral processes. Kneading, traction, compression, rotation of skin fold is carried out around the articulation and along the extremity in the direction of canal passing through the myofascial pain zone. Musculofascial relaxation is carried out by sequentially capturing tissues between fingers of both hands below and above the articulation with following tissue pressing, traction in axial direction and twisting in opposite directions for restoring muscular equilibrium. Large articulation mobilization is carried out by applying rhythmic flexion, extension, traction, compression and vibrating rotation under moderate patient resistance. Skin fold displacement is then applied in inguinal and auxiliary zones, in ulnar and popliteal fossa for eliminating stagnation phenomena in the extremities and restoring motor function of regional lymph nodes. After the measures being over, medicamentous treatment is applied by administering intracellular biogenous regulator agents like cytometadins administered into the blocked vertebral locomotor segment, costotransverse joint projection and into the trigger zones of periarticular tissues surrounding large articulations without violating capsule integrity by applying neurometamer principle taking into account preparation mechanism of action. To do it, each cytometadin is dissolved in 4 ml of 2% lidocaine solution at a dose of 0.1 g of dry substance and is sequentially administered in 4-5 algetic points. The total treatment course is 8-10 daily sessions long. EFFECT: enhanced effectiveness of treatment; prevented pain attacks recurrence up to three years long.
